Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis

Detalles Bibliográficos
Autores principales: Doms, J., Prior, J.O., Peters, S., Obeid, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229714/
https://www.ncbi.nlm.nih.gov/pubmed/32425357
http://dx.doi.org/10.1016/j.annonc.2020.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229714/
https://www.ncbi.nlm.nih.gov/pubmed/32425357
http://dx.doi.org/10.1016/j.annonc.2020.05.005

Ejemplares similares